Skip to content
Noah Petermann, Epigenetics & Biomarkers

Noah Petermann

Co-founder & CEO of Aniva Health

Aniva Health

Co-founder & CEO, Aniva Health (Berlin) · Berlin chapter

Noah Petermann is co-founder and CEO of Aniva Health, a Berlin-based health-tech startup founded in 2025. Aniva's 100+ biomarker blood test and personalized action plans bring preventive, data-driven medicine to 25+ testing locations across Germany.

Highlights

  • Co-founded Aniva Health (legal entity Livy Health GmbH) in Berlin in 2025 together with Jan Clemens Hecker; serves as CEO and managing director.
  • Built Aniva's blood testing offering covering 100+ biomarkers (expandable to 500), with results in 7 days at 25+ testing locations across Germany, including Berlin, Hamburg, Munich, Frankfurt and Cologne.
  • Secured institutional backing for Aniva from investor Tetrad within the company's first year.
  • Created ugtax.de, a free open-source tool that helps German holding companies file their annual financial statements.

Co-founded Aniva Health (legal entity Livy Health GmbH) in Berlin in 2025 together with Jan Clemens Hecker; serves as CEO and managing director.. Built Aniva's blood testing offering covering 100+ biomarkers (expandable to 500), with results in 7 days at 25+ testing locations across Germany, including Berlin, Hamburg, Munich, Frankfurt and Cologne.. Secured institutional backing for Aniva from investor Tetrad within the company's first year.. Created ugtax.de, a free open-source tool that helps German holding companies file their annual financial statements..

About Noah Petermann

Noah Petermann is co-founder and CEO of Aniva Health, a Berlin-based health-tech company building the infrastructure for preventive, data-driven medicine. Aniva turns routine bloodwork into personalized risk profiles, so consumers and their doctors can act years before symptoms appear. Before founding Aniva, Noah worked a variety of VC-backed HealthTech & BioTech StartUps, in Venture Capital & holds a degree from Humboldt-University of Berlin.

Education

Topics & Expertise

  • Epigenetics & Biomarkers
  • blood biomarker testing
  • preventive, data-driven medicine
  • biological age assessment
  • consumer health-tech
  • health data infrastructure
  • health-tech venture building

Talks at Longevity USA

Past

  • KNOW YOUR NUMBERS: The Biomarkers That Matter for LongevityJun 24, 2026 · Jodel Office, Willhelmsstraße 118, 10963 Berlin

Frequently Asked

Who is Noah Petermann?

Noah Petermann is a Berlin-based entrepreneur and the co-founder and CEO of Aniva Health, a health-tech company he started in 2025 with Jan Clemens Hecker. Aniva turns routine bloodwork into personalized risk profiles so people and their doctors can act years before symptoms appear. He holds a degree from Humboldt-Universität zu Berlin and previously worked at VC-backed health-tech and biotech startups and in venture capital.

What does Noah Petermann's company Aniva Health do?

Aniva Health offers a membership-based preventive health service built around a comprehensive blood test covering 100+ biomarkers (expandable to 500), spanning vitamins, hormones, inflammation and metabolism. Members get results within 7 days, a biological age calculation, a personalized action plan and year-round access to health experts, with data stored securely in the EU. Testing is available at 25+ locations across Germany.

Is Aniva Health based in Berlin?

Yes. Aniva Health was founded in Berlin in 2025 and operates through the legal entity Livy Health GmbH, Kolonnenstraße 8, 10827 Berlin, registered at the Charlottenburg local court (HRB 272567 B). Noah Petermann and Jan Clemens Hecker are its managing directors. From Berlin, Aniva runs 25+ testing locations across Germany.

What is Noah Petermann's background?

Noah Petermann holds a degree from Humboldt-Universität zu Berlin. Before co-founding Aniva Health in 2025, he worked at several VC-backed health-tech and biotech startups and in venture capital. He also built ugtax.de, a free open-source tool for German holding companies to file annual financial statements.